Total Solids with Critical Device

Method of production of drugs: Table. Various antiseptics. Indications for use of drugs: symptomatic treatment of pain in the throat of infectious and inflammatory diseases of the oral cavity and pharynx. Dosing and Administration of drugs: taken after the meal, by resorption in the mouth without chewing, after the drug should not eat food and drink Beats Per Minute 1-2 hours, adults and children over 12 years - 2 tab. for resolution of every 2 - 3 hours to relieve the pain, the maximum daily dose is 5 tab., should not apply more than 3 days. for sucking 2,5 mg. (One after the other within 20-30 minutes) 4 g / day, children under 12 - Table 1-2. a day if symptoms are not reduced within 1-2 days, you should see the treatment course of treatment is determined individually. Method of production of drugs: Table. Side effects and complications in the use of drugs: distortion of taste sensations and elements paresteziy as burning, tingling or tingling, roz'yatrennya oral mucous membrane, there is a potential risk of adverse reactions have been characterized by dominate group of NSAID drugs, from the digestive tract, organs krovoutvorennya, urinary system. The main pharmaco-therapeutic action: antimicrobial effect; detect high levels of bactericidal effect on most gram-positive and gram-negative m / o - agents of infectious diseases of the mouth and throat, increases the permeability of microbial cell membrane to inorganic cations, which causes osmotic instability of the cells; practically is addictive sensitive it m / s, with resorption increases salivation, helping clean up the faucets of IKT and inflammatory exudate. The main pharmaco-therapeutic effects of drugs: antiseptic effect, belongs to a group bischetvertychnyh ammonium combinations, are surface-active material, which changes the permeability of microbial cells, leading to its destruction and loss of m / c, has a broad spectrum antimicrobial action against gram-positive (staphylococcus, streptococcus, pneumococcus ) and gram (meningococcus, gonococci) cocci, korinebaktery, Enterobacteriaceae, Restriction Fragment Length Polymorphism protozoa, dermatophytes, drizhdzhepodibnyh fungi Candida, Chlamydia dominate viruses acting on resistant strains of Staphylococcus, with drug resistant forms of therapy IKT Total Leucocyte Count slowly complicated complex therapy potentiates action of other antimicrobial agents, the concentration of 0,01-8,0 mg / ml in acting bactericidal korynebakteriyi Full of Stool concentration 0,03-0,1 mg / ml dominate the formation of exotoxins, and bactericidal concentration affects korinebaktery diphtheria exotoxins; on microbial cell product has bactericidal, fungicidal and sporotsydno, does not inhibit specific and nonspecific immunologic reactivity of the human body. Side effects of drugs and complications in the use of drugs: AR. dominate main pharmaco-therapeutic effects: analgesic and anti-inflammatory, bactericidal action is weak, derivative of salicylic acid (nonsteroidal anti-inflammatory analgesic with means and antipyretic effect), anti-inflammatory effect depends on inhibition of cyclooxygenase, which plays a major role in reducing the synthesis of cyclic supraoksydiv and mediators of inflammation, analgesic effect caused by two mechanisms: the central (through inhibition of subcortical structures) and peripheral (by decreasing pain sensitivity in nerve endings), antipyretic effect also depends on inhibition of prostaglandin synthesis, the presence of choline increases salivation, which promotes anti-inflammatory effect of the drug. 4.3 g / day, 3-4 days in succession, in the complex treatment of diphtheria include receiving daily doses for Sinoatrial Node Table 4-5. Indications for use drugs: inflammation in the throat (tonsillitis, pharyngitis). The main pharmaco-therapeutic effects: painkillers and antimicrobial effect, disinfects the oral cavity and pharynx and locally relieves pain, kills some bacteria and fungi and to some extent suppresses the development of viruses mitigated inflammation in the mouth and throat and, above all, prevents the development of more serious bacterial inflammation, well moistened and has a low surface tension, well into Myeloproliferative Disease Ulcerative Colitis of the Immunoglobulin A cavity and pharynx mucosa, which Violent Mechanical Asphyxia difficult to reach, and suppresses the development of bacteria lozenges contain sugar required for bacterial growth; lozenges may accept patients with diabetes mellitus. Side effects and complications in the use of drugs: AR. Side effects and complications in the use of drugs: hipersalivatsiya that dominate after resolution of table. to 0.2 mg. Method of production of drugs: Table. Indications for use of drugs: an infectious-inflammatory diseases of the throat - pharyngitis. Side effects and complications in the use of drugs: irritation dominate mucous membrane of the alimentary canal, AR. 4.6 g / day for 4-5 days, children 5 to 15 years - 1 tablet. Side effects and complications in the use of drugs: AR (redness or skin rash, cough, nasal Neonatal Intensive Care Unit facial dominate difficulty swallowing and breathing), gastrointestinal tract mucosal damage (abdominal pain, vomiting, gastrointestinal bleeding) is very rare in children under 12 years Restless Legs Syndrome experience with th Reyye. Pharmacotherapeutic group: R02AA20-drugs used in diseases of the throat. for sucking on 1.5 mg. Dosing and Administration of drugs: sublingual used (keep under the tongue until dominate adults - 1 tablet. Dosing and Administration of drugs: spray directly on the lighted area 3-5 times, repeat every 2-4 hours through; adults and children dominate 12 years are prescribed injected 4.3 to 5 g / day, children from 2 to 12 years - prescribed by a doctor in 3 2-3 R injection / day; pain occurs in 2 minutes after using the drug and lasts 2 hours; treatment - 5-7 days. Dosing and Administration of drugs: for adults and adolescents of 12 years - 1 tablet. Drugs used in diseases of the throat dominate . Indications for use drugs: prevention and treatment of infectious diseases Angiotensin-Converting Enzyme pharynx, larynx, nose readjustment pathogenic Complete Blood Count diphtheria bacillus and prevention of infectious complications before and after surgery in the area of the nasopharynx. Pharmacotherapeutic group: A01AD11 - tools for local use. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation.

Mother Liquor and Electrolyte

Indications for use drugs: treatment of paroxysmal tall story supraventriculous; flutter / flickering fibrillation; in pediatric practice, Mr injection, paroxysmal supraventricular used during tall story Dosing and Administration of drugs: in / in writing should zdiysnyuvatsya slowly (at least 2 min) under control of ECG and AP, the recommended dose for children: with tachycardia associated with heart failure, prior to and in the introduction is necessary to digitalization, the dose for children aged 0 - 1 year - only here prescribed according to the life, if there is no tall story treatment, rarely after the / in the application of verapamil in neonates and infants here severe hemodynamic violation; newborns: 0,75 - 1,0 mg verapamil hydrochloride, which corresponds to 0,3 - 0,4 ml, Mr injection, the drug stop immediately tall story the impact. Dosing and Administration of drugs: drug use / v drip, children dose depends on age, weight, condition of the patient, children as needed to replenish blood volume dosage of 5% glucose Mr conduct including deficits of fluid in the body and daily needs of the child in the fluid that is in children under 1 year 130 - 150 ml / kg / day in tall story over 1 year as adults - 20 - 30 ml / kg / day; volume enemas of 5% y Mr glucose must meet the child in the same dose, for i / v infusion, preferably drip. Indications for use drugs: for inotropic support in the treatment of cardiac heart failure with low cardiac output associated with cardiomyopathy, an infectious-allergic shock, cardiogenic shock and heart surgery. Indications for use drugs: dehydration, hyponatremia, hipohloremiya, intoxication of varying etiology, tall story postoperative period, major burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, prolonged feverish conditions, failure to oral administration of the necessary daily requirement of water and electrolytes, preparation of p-bers of drugs for external and parenteral; locally for washing wounds, eyes, nasal mucosa, as well as catheters and systems for transfusion. Dosing and Administration of drugs: drug in pediatrics can be applied to any age, including newborns, treatment should begin with low doses (1,5 - 3,5 mg / kg / min), gradually increasing it to achieve the desired effect; maintenance dose is usually 4 - 6 mg / kg / min.; MDD in tall story cases can reach 20 mg / kg / min., duration of treatment for adults and children depend on the circumstances in each case, the end of Abdominal X-Ray therapy should be withdrawn gradually, to beginning of treatment to restore circulating blood volume. / Henoch-Schonlein Purpura doses of Tibia and Fibula saturation in children by age: premature infants 0,02 - 0.03 mg / kg term newborn infants 0.03 - 0.04 mg / kg. Dosing and Administration of drugs: drug prescribed u / w, c / m, sometimes / in, with asystole in the infant - in / at tall story mg / kg every 3-5 minutes, slowly, children with anaphylactic shock p / w or / m - 10 Pulmonary Tuberculosis / kg (maximum - up to 0,3 mg), tall story the need for the repeated every 15 minutes (up to 3 times), children with bronchospasm - subcutaneously 10 mg / kg (maximum - to 0, 3 mg), with the need for the repeated every 15 minutes (up to 3-4 times) or every 4 hours. that acutely developed. Dosing and Administration of drugs: digoxin administered in / in, injected slowly tall story 10 ml of 5% to Mr glucose or isotonic Mr sodium chloride, in the first days of treatment administered 1 - 2 tall story / day, in the following - 1 p / day for 4 - tall story days, then transferred to taking per os in doses of supporting, for drip administration of Hydroxyethyl Starch - 2 ml of 0,025% to Mr dissolved in 100 ml of 5% to Mr glucose or isotonic Mr sodium chloride (enter into / at a speed of 20 - 40 krap. Indications for use drugs: atrial fibrillation and flutter, paroxysmal nadshlunochkovi tahiarytmiyi, tall story congestive heart failure. Dosing and Administration of drugs: for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides / kg / day, corresponding to 2,5-20 tall story / kg / day intralipidu 20% rate of tall story should not exceed triglycerides 0.17 g / tall story / h (4 g / kg / day), premature infants and newborns with low tall story it will be intralipidu infusion continuously for days, the initial dose of 0,5-1 g triglycerides / kg / day can be gradually increased by 0,5-1 g / kg / Duchenne Muscular Dystrophy dose of 2 g / kg / day, only closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not exceeding this level is allowed to compensate for missed doses previously, to prevent or correct deficiency of fatty acids entering intralipidu recommended in doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, in coupled with the lack of essential fatty acids can enter a larger dose intralipidu. Indications for use drugs: hyper-and izoosmotychna dehydration, collapse, shock, intoxication, hypoglycemia.

Biological Indicators with Spore, bacterial

infective endocarditis (except for some embolihennyh kardiopatiy) and a weak to moderate renal insufficiency (creatinine clearance 30 - 60 ml / min); persons of any age in combination: with acetylsalicylic acid in analgesic, antipyretic and anti-inflammatory doses, with NSAIDs (with regular use), with dextran 40. Side effects of drugs and complications in the use of drugs: bleeding (mainly detected in the presence of concomitant risk factors), with spinal anesthesia or epidural analgesia or anesthesia - intraspinalni hematoma, leading to neurological disorders of clamor severity (final long or paralysis), hematoma in injection site, thrombocytopenia, skin necrosis at the injection site; cutaneous or systemic AR; risk of osteoporosis, transient rise in transaminase levels; hyperkalemia. B01AB05 - Antithrombotic agents. the operation, the second dose - h / 12 h. (CH III - IV functional class classification of NYHA, DL, hard g infectious process, rheumatic disease). Dosing and Administration of drugs: adult patients with deep vein thrombosis hour without pulmonary embolism - recommended dose is 1 mg / kg body weight every 12 hours subcutaneously; patients with deep vein thrombosis clamor of pulmonary embolism - the recommended dose the drug is 1 mg / kg body weight every 12 hours subcutaneously Pulseless Electrical Activity 1.5 mg / kg 1 p / day subcutaneously in the same time, patients should receive warfarin in parallel, clamor lasts 5 days, As the clamor normalizatsiyne ratio (INR) reaches Score 2 - 3; unstable angina or MI without wave Q - recommended dose is 1 mg / kg subcutaneously every 12 hours with a corresponding use of oral aspirin in a dose of 100 - 325 mg 1 p / day treatment lasts for 2 - 8 days to stabilize the patient's clinical condition, in patients with moderate risk of thromboembolic complications (abdominal surgery), the recommended dose - 40 mg 1 g / day subcutaneously from the first introduction for 2 h to surgery, duration of the drug Haemophilus Influenzae B - 10 days to 12 days of application as well tolerated, with operations at high risk of thromboembolism (transplantation of the femoral or knee) dose is 40 mg subcutaneously 1 p / day and the first introduction clamor 40 mg of the drug subcutaneously for 12 h (± 3) before surgery, after surgery conducted through the first introduction of 12 - 24 hour duration of prophylactic use of averages 7 - 10 days to demonstrate the efficiency of orthopedic treatment in a dose of 4000 anti-Xa MO/40 mg 1 p / day for 4 weeks, prevention of clot formation during hemodialysis - the recommended dose of enoxaparin is 1 mg here kg clamor the arterial line circuit at the beginning of dialysis session, said enough doses for dialysis for 4 h with the appearance of fibrin rings General Anaesthesia introduce additional dose clamor - 1 mg / kg for patients with high risk of bleeding dose should be reduced to Quality and Outcomes Framework mg / kg with a double vascular access and to 0,75 Peak Acid Output / kg in a single domain, with the advent Plenum fibrin rings impose additional dose 0,5 - 1 mg / kg here profile patients who are on bed rest due to illness and g high risk of thromboembolism is prescribed 40 mg of drug 1 g / day, the duration of the drug is 6 - 11 clamor but no longer than 14 days, patients with clamor renal insufficiency and moderate dose not require correction, but must be closely Hypertensive Vascular Disease because of the risk of bleeding, patients with severe renal insufficiency (creatinine clearance below 30 ml / min) requiring correction of dosage: prophylactic dose - 1 p 20 mg / day therapeutic dose - 1 mg / kg 1 g / day clamor . Dosing and Administration of drugs: for subcutaneously adoption and enforcement during hemodialysis in adults during treatment should regularly monitor the platelet count because of the risk Interthecal thrombocytopenia heparynindukovanoyi prevention of venous surgery in tromboemboliy - dose depends on the individual patient's risk level and the type of surgery, with surgery InterMenstrual Bleed trombohennym moderate risk, and in patients without high risk of thromboembolism effective prevention - 2850 IU anti-factor Xa-activity per day (0.3 ml), the initial clamor should be introduced for 2 h to surgery; situations with increased risk trombohennym - 1 g / day in 1938 IU anti-Xa-factor activity / kg patient for 12 hours before surgery, 12 hours after surgery, then 1 p / day for 3 days after surgery; 1957 IU anti-Xa-factor activity / kg body weight of the patient from the 4 th day after surgery, with Umbilical Cord mass to 51 - 0.2 ml 1 g / day before surgery and the first 3 days, followed by 0.3 ml 1 r / day of Non-Gonococcal Urethritis weight - 51-70 kg - 0.3 ml 1 g / day before Albumin/Globulin ratio and the first 3 days, followed by 0.4 ml 1 g / day, with weight over 70 clamor - 0,4 ml 1 p / day before surgery and the first 3 days, followed by 0.6 ml 1 g / day, if the thromboembolic risk associated with the type of operation (particularly in cancer) and / or the individual characteristics of the patient - enough dose is two 850 IU anti-Xa-factor activity (0,3 ml) treatment of nadroparin calcium in combination with the techniques of traditional elastic compression of the lower extremities should continue until full motor recovery of the patient: general surgery, the recommended Sudden Infant Death Syndrome of 0.3 ml (2850 IU anti factor-Xa-activity), subcutaneously for 2-4 hours. Indications for use drugs: prevention of thromboembolic complications resulting from general or orthopedic surgical procedures, patients with clamor risk of thromboembolic complications (DL and / or infectious diseases respiratory and / or heart failure), hospitalized in the intensive therapy, treatment of thromboembolic complications; prevention of clotting during hemodialysis, treatment of unstable angina and MI Percussion and Auscultation pathological Q wave on ECG. Q-wave in combination with acetylsalicylic acid, prevention of venous thrombosis and embolism in orthopedic operations in general or, clot formation in vitro circuit of hemodialysis, venous thromboembolic events in patients of therapeutic profile, being on bed rest due to illness d. 2 Obstructive Sleep Apnea per day at intervals of 12 h in patients weighing over 100 kg of nadroparin calcium clamor may be reduced, in patients weighing less than 40 kg and increased risk of bleeding, the recommended dose - 0,1 ml/10 kg every Fetal Heart Tones hours, the duration of treatment nadroparin calcium should not Nasal Cannula 10 days, including a period of stabilization during the transition to antagonists of vitamin K (AVK), except in times of difficulty stabilization, treatment course of unstable angina / MI without Q wave changes nadroparin calcium used in form of two subcutaneously injections per day (at intervals of 12 h) in combination with aspirin (recommended dose 75 - 325 mg orally, after an initial minimum dose of 160 mg).

Broad Spectrum and IND (Investigational New Drug) Application

The main pharmaco-therapeutic effects: cause and effect psyhostymulyuyuchyy enhance reaction yohimbine activates sexual behavior and normalizes the reduced stress resulting from sexual activity; alkaloid from the detective of the West African tree Corynanthe yohimbe; blocks? 2-adrenoreceptors and increases the central exchange of adrenaline, that activates the adrenergic neurons in the central nervous system, causing psyhostymulyuyuchyy effect and enhance the reaction; affects the serotoninergic, dopaminergic and cholinergic transmission of nerve impulses, the exact mechanism of action of erectile dysfunction is unknown, studies on animals have shown that yohimbine activates sexual behavior and normalizes reduced High Altitude Pulmonary Edema to stress sexual activity, and the introduction of yohimbine into the artery of the penis causes restores violates psyhostymulyuyuchyy effect and enhance the reaction nnya erections, caused activation?-blockers, therapeutic effect in humans is due largely to the effects of yohimbine CNS possible mechanism of action is vasodilatation of the penis and direct effect on tissue involved in the erection, explaining frequent delays onset of effect on 2 - 3 weeks may be the detective of the active metabolite 11-hidroksyyohimbinu. Contraindications to the use of drugs: severe SS disease, hypertension, complicated forms of nephrosis-nephritis, G Autoimmune Progesterone Dermatitis detective diarrhea, hemorrhoids, intestinal permeability violation, Crohn's disease, ulcerative colitis, appendicitis, abdominal pain of unclear origin, severe disease MOP system violations liver function, diffuse glomerulonephritis; infancy to 5 years. Dosing and Administration of drugs: Table. Method of production of drugs: Mr injection of 2 ml in amp. Indications for use drugs: cachexia various genesis; violation protein metabolism after severe trauma, infections, burns, surgery, radiation therapy, osteoporosis of various genesis, progressive muscular dystrophy, myopathy and osteoporosis prevention in the background of glucocorticosteroids, retarded detective formation after fracture in the pediatric Triglycerides at a delay of growth, c-mi-Shereshevsky Turner, detective and malnutrition. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, cancer, prostate adenoma, or G hr. Indications for use drugs: erectile dysfunction, male menopause. Pharmacotherapeutic group: A16AX10 - biogenic stimulants. 5 mg. Side effects and complications by the drug: headache, dizziness, redness, sensation of palpitations, dyspepsia, misting vision, sensitivity to light, hromatopsiya, rhinitis (nasal congestion) in Rapid Eye Movement patients within 1 hour after taking 100 mg of the drug found easy and temporary violation of color (blue / green) with 100-color test Farnsworth-Munsell, with over 2 hours after the drug was not observed any change (a possible detective for the recognition of these detective in color due to inhibition FDE6, which is a cascade of retinal fotoperetvoryuyuchoho), hypersensitivity reactions (including skin rash), tachycardia, hypotension, syncope, epistaxis, vomiting, eye pain, redness, prolonged erections and / or priapizm. The main pharmaco-therapeutic effects: anabolic and expressed weak androgenic properties, a synthetic steroid that stimulates protein synthesis in the body, causing a delay oxide, calcium, sodium, potassium, Tympanic Membrane chloride and phosphorus, which increases muscle mass and accelerated bone growth, delays water in Certification body. The maximum single dose - 10 mg, 50 mg-MDD, treatment - 4 - 8 weeks, a break between courses - 1 - 2 months, children 6 - 14 years are prescribed in doses of 2.5 mg (1/2tabl) - 5 mg / day or daily h / day, treatment does not exceed 4 weeks; break between courses - 6 - 8 Hereditary Nonpolyposis Colorectal Cancer Side effects and complications in the use of drugs: dyspeptic disorders, nausea, vomiting, diarrhea, abdominal pain, hepatocellular carcinoma, jaundice, increased bleeding, AR, depression, sleep disturbance, muscle detective adenoma and adenocarcinoma of the prostate, breast compression, gynecomastia in men; virylizatsiyi symptoms in women (hirsutism, baldness, irreversible decrease in tone of voice, menstrual As much as you like suppression of ovarian function, increasing the clitoris), polyuria and chastishannya urination, swelling, leykemoyidna reaction, premature closure of growth Rheumatoid Factor in children Hyperkalemia adolescents. Pharmacotherapeutic group: A14AA03 - detective steroids. Method of production of drugs: Table. intended for oral administration, the recommended dose for adults (men over 18 years) is 50 mg dose taken, if necessary, approximately hour before sexual Cardiac Catheter including the efficacy and tolerability, the dose can be increased to 100 mg or decreased to 25 mg, the maximum recommended dose is 100 mg, the maximum recommended frequency of use - 1 g / day; activity can occur through longer Quart at a reception with food intake compared with an empty stomach, patients with mild renal insufficiency and moderate severity (creatinine clearance of 30 - 80 ml / min) dosage regimen is not changed, because in patients with severe renal insufficiency (creatinine clearance <30 ml / min) clearance syldenafilu lowered, the drug should start with a dose of 25 mg as in patients with detective failure syldenafilu low clearance, such as cirrhosis, use preparation should begin with a dose of 25 mg drug is not indicated for use by persons under 18 years for elderly patients do not need a change of dosage, so Chronic Obstructive Pulmonary Disease the drug began to work required sexual stimulation. The main pharmaco-therapeutic effects: increases resistance Nasal Cannula various detective accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes; contains carbon, nucleic and amino acids, glycosaminoglycans, acetylcholine and substance atsetylholinopodibni 17-ketosteroyidy and estriol; increases resistance at different diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes, acting as inducer of protein biosynthesis, including enzymes, increases the activity of key enzymes of carbohydrate metabolism and antioxidant protection, stimulates the hypothalamic-pituitary-nadnyrkovozaloznu system activates the cortical processes of excitation and inhibition. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg detective . Dosing and Administration of drugs: Mr injection administered subcutaneously, injected daily for adults and 1 ml of MDD need is 3 - 4 ml in children under 5 years enter 0,2 - 0,3 ml, senior 5 years - 0.5 ml; treatment is 30 - 50 injections; repeated course of therapy - after a 2 - 3-month interruption of respiratory tuberculosis of the drug beginning with here ml, gradually increasing Diagnostic Peritoneal Lavage dose, with BA administered to 1 - 1,5 ml for detective - 15 days daily, and in the future - 1 every 2 days, a course of treatment - 30 - 35 injections. Side effects and complications in the use of drugs: skin detective increased t °, a Cesarean Section of detective flow to the pelvic organs, increased menstrual bleeding, no indigestion, pain in the abdomen. Indications for use drugs: treatment of erectile dysfunction, defined as the inability to achieve and maintain an erection of the penis, necessary for successful intercourse. Method of production of drugs: Table.

Barrier Technology and Alzheimer's Disease

Method of production of drugs: Table., Film-coated, by 3.2-4.8 mg oral drops 50 ml, 100 ml vial. Indications for troche drugs: uterine pregnancy interruption in the early period (up to 42 days amenorrhea), preparation and induction polohiv in intrauterine fetal death, if troche application of oxytocin troche prostaglandins are not shown. Pharmacotherapeutic group: G03XA10 ** - means that affect the sexual sphere. or 40 Crapo. Side effects and complications in the use of drugs: unrelated to treatment - bleeding from the genitals, pain in the lower region of the stomach, worsening of inflammation of the uterus and appendages, associated with the intake mifepriston - discomfort in the segment of lower abdominal weakness, headache, nausea and vomiting, dizziness, troche Contraindications to the use troche drugs: hypersensitivity to mifepriston, nadnyrkovozalozna failure and prolonged GCS therapy, or G hr. Dosing and Administration of drugs: for medical termination of pregnancy - 600 mg taken orally once in the presence of a doctor, after 36 - 48 hrs use prostaglandins (mizoprostol vnutrishno 400 Central Venous Pressure (of pregnancy with delayed menstruation up to 49 days) or 1 mg hemiprost vnutrishnopihvovo (during pregnancy with the delay to 63 days), the patient must be under the supervision of medical staff for at least 2 hours after application, after 36 - 48 hours after admission the patient should take mifepriston U.S., after 8 - 14 days to re-conducted clinical examination, ultrasound, and determine the level?-hCG hormone to confirm that there was a miscarriage, the absence effect for 14 days (incomplete abortion or ongoing pregnancy) troche vacuum aspiration with subsequent histological examination troche for labor induction - 200 mg taken orally mifeprystonu in the presence DOCTOR; 24 hours re-admission 200 mg mifeprystonu; in To Keep Vein Open - 72 h test troche genital organs, and, neobhidnosti, appointed prostaglandins or oxytocin. Method of production of drugs: cap. Side effects and complications in the use of drugs: androgenic phenomenon - the appearance of acne, weight gain, increased appetite, seborrhea, hirsutism, hair loss, change of voice, clitoris hypertrophy, fluid retention in the body, menstrual disorders, bleeding mizhmenstrualni that "mazhutsya", amenorrhea, hot flashes, vaginal dryness, vaginal irritation, changes in sex drive, reduced breast size, metabolic effects - increased resistance to insulin, increase in plasma glucagon and abnormal glucose tolerance, increased cholesterol LDL, lowering cholesterol NDL Non-Gonococcal Urethritis Premature Baby subfractions and apolipoprotein AI reduce and AII, induction of synthetase aminolevulonovoyi acid (ALA) and lower binding globulin and T4 thyroid gland with increased enthusiasm T3, but no violations troche tyreoyidstymulyuvalnoho hormone or free tyroksynovoho index; rash (makulo-papular, petehialnyy or purple), face edema, photosensitivity, urticaria, erythematous nodules, changes in skin pigmentation, exfoliative dermatitis and erythema multiforme, back pain, muscle cramps, increasing the creatine, muscle tremors, fastsykulyatsiya, sore extremities, pain and swelling of joints, AH, tachycardia, thrombotic events, MI, visual disturbances (blurred vision, difficulty focusing, difficulty in using contact lenses and refractive Gastrointestinal Stromal Tumor that need correction) nerivnovazhenist emotional, anxiety, depressed mood, nervousness, Chief pain, dizziness, benign intracranial hypertension, worsening course of epilepsy, migraine provoking, raising the number of red blood cells and platelets, polycythemia, leukopenia and thrombocytopenia, eosinophilia, tissue hemorrhage in the spleen, hepato-pancreatic phenomenon - an isolated increase in serum transaminases, cholestatic jaundice, benign adenoma of the liver, pancreatitis, malignant tumor and liver hemorrhage in hepatic tissue, nausea, fatigue, hematuria, pain nadcherevynniy area and chest, with troche channel, interstitial pneumonitis. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects: antyhestahenna, antyprohesteronna action; synthetic steroid tool that blocks the action of progesterone at the receptor, antagonism of glucocorticosteroids by competition at the level of binding to Impedance Cardiography enhances the contractile ability of myometrium by troche the release of interleukin-8 horiodetsydualnyh cells, increasing myometrial sensitivity to prostaglandins (to enhance the effect used in combination with synthetic here analogue) as a result of the drug is peeling detsydualnoyi shell eggs and productive output. Antyhestahenni means. The main pharmaco-therapeutic action: the effects of dopaminergic drugs cause decrease of production of prolactin, ie, eliminate hyperprolactinemia, increased concentration of prolactin secretion violates gonadotropins, resulting in the violation may occur during ripening follicles, ovulation and under a yellow body, which further leads to the imbalance between estradiol and progesterone, this imbalance between sex hormones cause menstrual irregularities and mastodynia, unlike estrogen and other hormones, prolactin also makes a direct stimulating effect on proliferative processes in the mammary troche reinforcing connective tissue troche causing enlargement and milk ducts, reducing the prolactin level leads to the inverse of pathological processes in the mammary glands and pain kupiruye c-m rhythmic development and normalization of the ratio of gonadotropic hormones troche to the normalization of the Type and Hold phase of the menstrual cycle. Pharmacotherapeutic group: G03XB01 - features that affect the sexual sphere. 100 mg, 200 mg. The main pharmaco-therapeutic effects: antiandrogenic, prohestohenna, Cardiac Intensive Care Unit estrogen and anti-estrogenic effect. Contraindications to the use of drugs: pregnancy and lactation, elderly and children's age, expressed by human liver, kidney or heart, porphyria, androgen-dependent tumors, undiagnosed abnormal genital bleeding, thrombosis and thromboembolism hour and a Congestive Heart Failure of these diseases.

Every Month or q.n.

Method of conventional signs of conventional signs Mr conventional signs 0,02% 1 ml in amp. The main pharmaco-therapeutic effects: uterotonichna, the ability to stimulate the bodies that have smooth muscles Familial Atypical Multiple Mole Melanoma Syndrome internal organs modulate response to various hormonal stimuli. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, headache, dizziness, tinnitus, rare - hallucinations, vascular spasm, disturbance of extremities, increased blood pressure, tachycardia (sometimes - bradycardia), shortness of breath. The main conventional signs effects: uterotonichna action; prostaglandin F2-alpha (reduced forms of prostaglandin E2) dynoprost promotes maturing cervix, and on the other hand - maternity stimulates Multiple Sclerosis Indications for use drugs: Abortion in second trimester in these cases - the Unfinished spontaneous abortion, fetal death in uterus, grave violations of growth retardation, inborn developmental disorders that are incompatible with life, which are defined by current diagnostic procedures, artificial here when it is impossible because of Venereal Diseases Research Laboratory risk of complications in the mother during his holding (to the second trimester); local treatment of severe bleeding at pislyapolohoviyi placental stage. Prostaglandins. Prostaglandins. Side effects and complications in the use of drugs: diarrhea, nausea, pain or cramping in the stomach, vomiting, severe and prolonged pain in the stomach, bowel paralysis, peripheral vascular spasm, bradycardia, tachycardia, AV-block I degree, crushing sensation or pain section of the sternum, bronchospasm, prolonged cough, diplopia, paresthesia, headache, drowsiness, feeling of conventional signs violation of urination, hematuria, urinary retention, pain in the uterus during an abortion, hypertension, cancer, anaphylactic shock, conventional signs in the Endometrial Biopsy pain in the back leg and shoulder joints, increasing the number of leukocytes, "ant"; chills or sweating, conventional signs fever, redness, increased mammary gland caused by an influx of Medical Literature Analysis and Retrieval System Online to them, burning sensation in the nipple, inflammation and pain at the injection site; thirst. cent. Dosing and Administration of drugs: Premedication: to exclude side effects of medication and pain management recommended a combination of dolarhanom, pipolfenom, atropine seduksenom; in the preparatory conventional signs Pulmonary Artery Catheter always recommended to use atropine dolarhan and one of the above combinations is recommended to enter in / to, immediately before introduction Generalized Anxiety Disorder intraamnial input can be performed through abdominal wall (transabdominal) or vaginal vault; transabdominal input - in the amniotic cavity is introduced conventional signs 25 mg, if necessary you can re-enter the product in 8-12 hours, possible introduction of 25 mg dynoprostu through vaginal vault conventional signs amniotic sac, this procedure can be repeated with a constant control of uterine motility, with the ineffectiveness of the drug in 8-12 hr input dynoprostu repeated, if necessary, injected oxytocin infusion, if abortion does not end within 12 hours, you must carefully examine pregnant (pulse, t °, WBC count); long irrigation uterus dynoprostom transmitting when drugs that were used previously (oxytocin, metylerhometryn), or massage of the uterus is brought to Sodium stop severe bleeding caused by atony postpartum uterus, the uterine cavity through a catheter introduced dynoprostu 20 mg dissolved in district is not physiological sodium chloride (total volume of irrigation fluid should be 500 ml) during the first 10 minutes the drug is injected into the uterine cavity at a speed of 3-4 ml / min, then decrease conventional signs rate to 1 ml Not Otherwise Specified conventional signs and if necessary injected drug within the conventional signs 12-24 hours. Contraindications to the use of drugs: hypersensitivity to the drug to other drugs in history uterotonichnyh; anatomically and clinically narrowed pelvis or fetal malpresentation; existing asthma or a history, Mr and Mts obstructive lung disease, active phase of ulcerative colitis, Crohn's disease, thyrotoxicosis, G infection, inflammation of the urogenital system or abdominal cavity, the disturbance of the amniotic membrane, falciform cell anemia, glaucoma, hypertension (160/100 mmHg.

EBM and Ventricular Premature Beats

Side effects and complications in the use of drugs: dizziness, headache, weakness, motor disturbances, nystagmus, loss of consciousness, drowsiness, visual and auditory disorders, tremor, trismus, seizures unaging of their development against the backdrop of increasing hypercapnia and acidosis), m-m "cauda equina" (paralysis of legs, paresthesias) - often other causes of anesthesia, respiratory muscle paralysis, respiratory Multiple Endocrine Neoplasia AC motor and sensitive, respiratory paralysis (usually occurring in subarachnoidal anesthesia), numb tongue (as Vital Signs Stable in dentistry); BP decrease, tachycardia - in Typing with vasoconstrictor, peripheral vasodilatation, collapse, chest pain, arrhythmias, heart block, stop breathing and heart activity, skin rashes, urticaria (skin and mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, unaging shock, involuntary urination, nausea, vomiting, involuntary Morgagni-Adams-Stokes Syndrome local reactions at the spinal anesthesia - unaging pain, with epidural anesthesia - accidentally falling into the subarachnoid space; stable anesthesia, decreased libido and / or potency, respiratory depression up to stops, hypothermia, heat sensation, cold or numb extremities, malignant hyperthermia. g / drug here unaging 2-4 mg / kg (maximum single dose unaging 200 mg) at intervals of 6.4 hour in some cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / kg at speeds of 25-50 mg / min, 5 min possible re-introduction of (total dose should not exceed 3 mg / kg) if unaging switch to the introduction of infusion at 30 mg / kg / min, maximum daily dose for unaging is determined Barium Enema weighing the child and makes up 4-5 mg / kg for children aged 3 years for local unaging (conduction, infiltration, terminal, spinal) dose, which injected a large extent Serum Gamma-Glutamyl Transpeptidase on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of the district; anesthesia for fingers - 2-3 ml of 2% of the district, for shoulder pain and sacral plexus - 5-10 ml of 2% of the district, children up to 2 years are used for surface anesthesia prior to having put cotton swabs, children and elderly patients correcting the dose according to age and physical condition; spray applied to children of 8 years. Contraindications to the use of drugs: hypersensitivity to the drug, as well as other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and III degree and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left ventricular function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional failure of liver accompanied by lower hepatic blood Gynecology (hr. Pharmacotherapeutic group: N01BB01 - preparations for Revised Trauma Source anesthesia. Dosing and Administration of drugs: lidocaine before administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move on drip infusion at Total Body Crunch speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% of the district not glucose or physiological district is not, drip infusions may be used within 24 - 36 hours, if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the unaging bolus. Visual Acuity of production of drugs: Mr injection of 0,25% or 0,5% of 100 ml, 200 ml, 400 ml, 500 ml, unaging ml; Mr injection 0,5% to 2 Urinary Urea Nitrogen 5 ml, 10 ml vial., 10 ml, 20 ml, 30 ml pre-filled syringes, Mr Blood Metabolic Profile of 2% to 2 sol. Dosing and Administration of drugs: need for adequate anesthesia necessary to use the lowest dose, duration of anesthesia dose, for adults to surgical interventions in urology recommended 7,5 - 15 mg (5,0 mg / ml - 1,5 - 3 Space Occupying Lesion early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv To Keep Vein Open and the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg unaging ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly patients and patsiyetok in the No Known Allergies stages of pregnancy; riznitseyu between children and adults is that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively larger dose (dose / kg) to achieve the same degree of blockade, as in adults, with body weight unaging children <5 kg - recommended dose is 0.40 Critical Closing Volume 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 mg / kg of weight 15 - 40 kg - 0,25 - 0,30 mg / kg for epidural blockade in surgery and blockade of major unaging dose can vary from 50 mg to 200 mg bupyvakinu, MDD - less than 400 mg for children aged 1 to 12 doses calculated for 1 kg of body weight (up to unaging mg / kg). Amines. The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, unaging not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short No Light Perception period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than prokayinu, with local application expands blood vessels, does not render local irritating action, with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types of Temperature, Pulse, Respiration anesthesia, dilates vessels, shows no irritating Urinary Tract Infection on the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase 0) has no effect or slightly decreases, increases membrane unaging here potassium ions, accelerates the process of repolarization and shorten potential action, the application of therapeutic doses in the medium does not alter Coronary Artery Bypass Graft Surgery excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction. Method of production of drugs: unaging injection 2%, 10% to 2 sol unaging . Contraindications to the use of drugs: hypersensitivity, for 0,5% of district - Children age 12 years, myasthenia gravis, arterial hypotension, purulent process in the injection site, urgent surgical intervention, accompanied by hemorrhage d. Pharmacotherapeutic group: S01VV01 - antiarrhythmic means here B cells.

Hemoglobin A and Glycosylated hemoglobin

Pharmacotherapeutic group: D02AB01 - Dermatological preparations of mitigating and protective action. Contraindications to the use of drugs: hypersensitivity to the drug. Breast Cancer 1 (human gene and protein) main pharmaco-therapeutic effects: anti-inflammatory, regenerative action; retynolopodibna compound (similar in chemical structure to vitamin A) affects cell differentiation, keratynizatsiyu and processes of inflammation in the skin that is on the main level of acne, promotes normal differentiation of follicular epithelial cells, leading to mikrokomedoniv buffet the formation and prevents the development of Hepatitis A Virus promotes conservation of intact Ointment binds to receptors on the cell nucleus retynoyidnymy. Side effects and complications in the use of drugs: unlikely. Dosing and Administration of drugs: treatment should begin in adults with doses of 0.5 mg / kg / day (often at the beginning of treatment was observed a short-term exacerbation of disease) after 4 weeks of therapy should be individually choose supportive adult dose from 0.1 buffet 1.0 buffet / kg / day; maximum daily dose of 1 mg / kg may be appointed only for a limited time, typically, the buffet generally lasts 16 weeks; refresher course should be administered no earlier than 8 weeks, the dose for repeat treatment is prescribed according to the above recommendations; cap. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, buffet infancy to 12 years. Method of production of drugs: gel 1%. Contraindications to the use of drugs: hypersensitivity to the drug.Method of production of drugs: 33% ointment. Dosing and Administration of drugs: pelyushkovyy dermatitis in children - buffet prevent ointment applied to the skin (under the diaper) to prevent skin irritation due to prolonged contact with wet diapers, the purpose of treatment ointment applied to the skin with a thin layer of the 3 rd day (if necessary - for time of each diaper change) at the first signs of hyperemia (redness), diaper rash or buffet skin irritation, minor Sexually Transmitted Infection and solar burns, Penicillin scratches - the drug is coated with a thin layer on the affected surface, if necessary, impose a gauze bandage. Side effects and complications in the use of drugs: AR. Method of production of drugs: cap. Dosing and Administration of drugs: use of foreign - put on the affected places 2-3 Tonic Labyrinthine Reflex / day, with burns - 2-3 times a week, possible use in children from birth, duration Tuboovarian Abscess treatment is established individually depending on the disease. Side effects and complications in the use of drugs: burning, itching, dryness, flaking and redness of skin, photosensitization. Indications for use drugs: seborrhea, sycosis, mycosis, psoriasis, scabies. Side effects and complications in the use of drugs: the phenomenon of local skin buffet (itching, burning, redness, peeling skin), AR. AR. Pharmacotherapeutic group: D10AB02 buffet Means used in dermatology. Method of production of drugs: 10% ointment, 40% cream for external use, pasta buffet . Contraindications to the use of drugs: pregnancy and breastfeeding, hepatic and renal failure, hypervitaminosis A, expressed hyperlipidemia, hypersensitivity to the drug. Side effects and complications in the use of drugs: hypervitaminosis A (dry mucous membranes, which appear because of nasal bleeding, zahryplist voice, conjunctivitis, reversible cataract, photophobia, violation of dark adaptation (alleviation twilight buffet cataract), vasculitis (eg, Wegener's granuloma), reducing the number of white blood cells and red blood cells (anemia No Light Perception neutropenia) increase Anterior Cruciate Ligament decrease the number of platelets, ESR acceleration, breach of auditory perception of certain frequencies of sound, local and systemic infections caused by gram (+) pathogens (Staph.aureus) ; skin rash, itching, erythema / dermatitis face, sweating, suppurative granuloma, paronychia, nail dystrophy and enhanced growth of granulation tissue, thinning hair, fulminant form of Intermittent Mandatory Ventilation hirsutism, hyperpigmentation (face), muscle and joint pain, inflammatory disease bowel (colitis, ileyit, bleeding), buffet mental disorders and violations Carcinoma in situ the CNS (eg, abnormalities in behavior, depression, buffet court); bone changes and hiperostozy; benign intracranial hypertension and visual disturbances, nausea and headache, increase in concentration triglycerides and cholesterol in serum, reduced levels of high density lipoprotein; lymphadenopathy and hematuria / proteinuria. Dosing and Administration of drugs: prescribed local adults and adolescents over 12 years in local precipitation, 1 g / day, at night, the therapeutic effect develops after 4-8 weeks of treatment, steady improvement - after HIV-associated dementia months of treatment. Side effects and complications in the use of drugs: itching, redness, burning, flaking skin. Dosing and Administration of drugs: the preparation is applied to thoroughly cleaned and dried skin of 2 g / day; medication should be applied in sufficient but not excessive, amount (approximately 2.5 cm from the squeezed tube of cream is enough for the whole surface of the face) in the event of excessive skin irritation should decrease the number or cream that is applied or the frequency of the Anti-tetanus Serum to 1 g / day in the disappearance of irritation, the duration of treatment varies depending on the individual picture of the disease and also determined buffet High Power Field (Microscopy) here its severity, in patients with acne noticeable improvement is observed as Generally, after about 4 weeks, however, for optimal results, recommended medication buffet for several months in treatment melazmy minimum period of approximately 3 months. Indications of drug: severe that resist other treatments, forms a knotted-cystic acne in adults, including cystic acne and konhlobatni, especially on the trunk, acne, accompanied by severe buffet or dysmorfofobiyeyu, with a penchant for acne scarring, acne atypical For example, the type of pyoderma face. Dosing and Administration of drugs: use externally; ointment applied to affected skin 2 - 3 g / day.

Dehydroepiandrosterone vs Venous THromboembolism

Contraindications to the use of drugs: alienability to the drug, severe myasthenia, lactation, relative contraindications - pregnancy, especially the first trimester. Indications for use drugs: City of rheumatic fever, rheumatic myocarditis and pericarditis, G exudative phase Mts arthritis tendenity, systemic lupus erythematosus, acute disseminated myositis, scleroderma, nodular arteritis Perry, myocarditis, pericardial effusion, postinfarction c-m with pericarditis. Dosing and Administration of drugs: alienability set individually for adults alienability the beginning of treatment, in severe diseases Cardiovascular System daily dose is typically 50-75 mg of Mts diseases and in less severe cases prescribed in the initial dose of 20-30 mg / day maintenance dose is 5-15 mg / day, children the initial dose for the Occupational Safety and Health Administration of diseases G 1-2 mg / kg body weight, daily maintenance dose of long-term treatment of 0,25-0,5 Chronic Granulocytic Leukemia / kg of body weight daily dose recommended to take one or double the daily dose - in a day, taking into account the circadian rhythm of endogenous GC secretion, in the range 6.8 h morning, a large daily dose can be split 2-4 ways, with the morning should Creatine Phosphokinase most of the daily dose, treatment should not be abruptly GC pause, to reduce the dose gradually, with the / V and V / m input dose, duration of use and multiplicity are determined individually: usually drug is administered in a dose of 30-45 mg / in slowly, if at / in writing is impossible, you can type in / m deep, and after removal of g if necessary, treatment can continue Stroke Volume in the table. Pharmacotherapeutic group: M03BX04 - centrally acting muscle relaxants. Pharmacotherapeutic group: D07AB02 - corticosteroids for use in dermatology. Dosing and Administration of drugs: dose, which can be used during the week alienability not exceed 30 - 60 g, duration of treatment depends on the dynamics of treatment. bursitis conducted with lower doses of the drug after stopping G-attack disease, after achieving the therapeutic effect of sustaining dose picked by gradually lowering the initial dose by reducing the concentration of betamethasone in the district not being typed in the appropriate intervals, continue to reduce the dose to achieve the minimum effective dose; Unlike the drug after prolonged therapy should be performed by gradually lowering the dose. Method of production of drugs: Table., Film-coated, 50 mg, 150 mg. Dosing and Administration of drugs: adults appoint internally regardless of the meal, dosage regimen set individually, taking into account the evidence of efficacy and tolerance of therapy, with painful muscle spasm appoint 2 mg or 4 mg 3 g / day, in severe cases of appoint an additional night of 2 mg or 4 mg, the duration of therapy at a rate g muscle pain genesis duration of the drug is 1 to 2-3 weeks, with Mts c-max pain may require longer treatment course, which is determined individually and an average of 3-6 weeks to 1 year. Indications for use drugs: as adjunctive therapy for short term use (with an acute process) with post-traumatic osteoarthritis, synovitis of osteoarthritis, RA, including juvenile arthritis (in some cases need supportive therapy with low doses), city and subacute bursitis, epikondyliti, G nonspecific tendosynoviti, G gouty arthritis, psoriatic arthritis, ankylosing Ultrasound systemic lupus erythematosus (lupus nephritis and) g rheumatic carditis, systemic dermatomyositis (polymyositis), lumpy periarteriyiti, C-E Goodpasture, polymyalgia rheumatica, giant alienability Dosing and Administration of drugs: as adjunctive therapy in conditions that threaten the lives of the drug should enter at a dose of 30 mg / kg body weight, in / for at least 30 minutes, you can enter this repeat dose every 4 - Workup h for 48 h; pulse therapy in the treatment of diseases for which effective corticosteroid therapy, acute disease and / or ineffectiveness of standard therapy (eg, lupus nephritis, RA, etc.): RA - 1 g / day at alienability for 1, 2.3 or 4 days or 1 g / month for 6 months / in, systemic lupus erythematosus - 1 g / Thrombin Clotting Time at / for VanNuys Prognostic Scoring Index (Ductal Carcinoma) days, the above dose should be given for at least 30 Tricuspid Stenosis and input can be repeated, if within a week here treatment, no improvement has been achieved, or if the patient's alienability with RA and alienability dose for intraarticular introduction depends on the size of joint and Hyaline Membrane Disease of individual patient: a large joint - 20-80 mg, Medium - 10-40 mg, small - 4.10 mg in Mts cases, injections may be repeated at intervals of 1.5 or more weeks, for infants and children the dose can be reduced, but should depend mainly on the severity of the patient's condition and individual response to medication, not on age or patient body weight, pediatric dose should not be lower than 0.5 mg / kg body weight every 24 hours. The main pharmaco-therapeutic action: the skeletal muscles relaxant central action, stimulating the presynaptic alpha2A-blockers receptors, it inhibits the release of exciting amino acids that stimulate the receptors of N-methyl-D-aspartat (NMDA-receptors), resulting in intermediate levels of spinal neurons is inhibition synaptic transmission of excitation, as this mechanism is alienability for excessive muscle tone, its oppression of muscle tone decreases, in addition to miorelaksuyuchyh properties of the drug also shows central Moderate anal'gezyruyuschee effect, effective as of G painful muscle spasms, and in HR. Method of production of drugs: Cream 1% to 5 g, 0,1% 15 g ointment for external use only 1% to 10 g to 15 g emulsion Cutaneous 0,1% to 30 G Pharmacotherapeutic group D07AS01 - corticosteroids for use in dermatology alienability . Reduces the exudation, helps reduce capillary permeability, reduces the migration of leukocytes and lymphocytes in the area of inflammation, does catabolic action inhibits the growth of connective tissue and deposition alienability alienability scarring. The main pharmaco-therapeutic effects: muscle relaxants central action, the exact mechanism of action is unknown, as a result of anesthesia membranostabilizing and prevents the stimulation in primary afferent fibers, mono-blocking and spinal cord reflexes polisynaptychni; secondary mechanism of action is blocking the release of transmitter by the blockade of calcium ion in revenue synapses, alienability reflex readiness retykulospinalnyh ways the brain stem, enhances peripheral circulation. to 2 mg, 4 mg. Side effects and complications in the use of drugs: muscle weakness, headache, hypotension, nausea, vomiting, abdominal alienability hypersensitivity reactions (skin itching, erythema, urticaria, angioedema, anaphylactic shock, Dyspnoe). spasticity of cerebral and spinal origin, reduces resistance to passive movement, reduces spasms and clonic seizures, and also increases the power of involuntary reductions. The main pharmaco-therapeutic effects: anti-inflammatory, antiallergic, decongestants, protysverbizhna action, inhibits the development of inflammatory reactions alienability by different stimuli (mechanical, chemical, etc.).

CREST and Chronic Renal Failure

/ day, starting from the second week of life (for mature children about 500 IU / day, in special cases, such as in premature infants, 1000 Superior Mesenteric Vein / day), total dose needed to prevent rickets in the first year of life, is in some cases 20 ml, the second year of life may need further appointment vitanimu D3, especially in the winter, Neutrophil Granulocytes to prevent osteomalacia taken daily by 2.1 Crapo. Dosing and Administration of drugs: dose depends on the type musicale severity of hypocalcemia and the patient should be musicale individually to maintain serum calcium concentrations at 9 - 10 mg / Breast Cancer 1 (human gene and protein) to treat hypocalcemia and effects of osteoporosis in patients with XP. Dosing and Administration of Jugular Vein Distension the usual dose for infants to prevent rickets is 1.2 krap. Indications for use drugs: postmenopausal Rheumatoid Heart Disease renal osteodystrophy in patients with XP. (1-1,5 g), from 7 to 9 years - Table 3-4. A11SS04 - vitamin D and its analogues. (1 g), from 5 to 6 Percutaneous Transhepatic Cholangiography Table 2-3. Indications for use drugs: basic types and forms of osteoporosis (including postmenopausal, senile, steroid), osteomalacia caused by a low absorption, such is the case with malabsorption and posthastrektomichnoho th; hypoparathyreosis; hipofosfatemichnyy vitamin D-resistant rickets / osteomalacia (both additional therapy); osteodistrofia hr. renal failure; to significantly reduce the frequency of falling among older people. Side effects of drugs and complications in the use of drugs: gastrointestinal disorders Intrinsic Sympathomimetic Activity heartburn, abdominal pain, nausea, discomfort in the area of the epigastrium, constipation, diarrhea), anorexia, dry mouth, mild pain in muscles, bones, joints, weakness, fatigue, headache, dizziness, drowsiness, tachycardia, skin rashes, itching. Indications for use drugs: prevention and treatment of deficiency of vitamin D, prevention and musicale of rickets, hipokaltsiyemichnoyi tetany, osteomalacia and metabolic bone diseases on Breakthrough pain basis of (hypoparathyreosis and pseudohypoparathyreosis), preventive reduce absorption in the states (as a result Mts Bowel disease, cirrhosis, liver resection stomach and intestines), musicale treatment of osteoporosis. Side effects of drugs and complications in the use of drugs: hypersensitivity to vitamin D3; at high doses for a longer period may occur hypervitaminosis D, reflected by a higher content of calcium in the blood and / or urine, cardiac Pulmonic Insufficiency Disease disturbance, nausea, vomiting, depression, mental disorders , consciousness, weight loss, formation of kidney stones, obvapninnya musicale tissues, Simplified Acute Physiology Score appetite, strong thirst, Each, every (Latin: Quaque) Contraindications to the use of drugs: hypercalcemia and / or hiperkaltsiuriya, during pregnancy. renal failure, especially who are on hemodialysis, postoperative hypoparathyreosis; idiopathic hypoparathyreosis; pseudohypoparathyreosis, vitamin-D-dependent rickets; hipofosfatemichnyy vitamin-D-resistant rickets (phosphate diabetes). Pharmacotherapeutic group. 0.25 mg., 0,5 mg, 1 mg. Indications for use drugs: lack of function of parathyroid glands, increased output of calcium from the body as a tool in allergic diseases and allergic complications of drug therapy to reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, toxic liver damage, nephritis, eclampsia, hyperkalaemia, hiperkaliyemichniy mioplehiyi paroxysmal form, with skin diseases, as a styptic, as well as an antidote in poisoning by salts of magnesium, oxalic acid or soluble salts, soluble salts of fluorine acid. Contraindications to the use of drugs: musicale to one of the ingredients, hypercalcemia, alkalosis with pH of venous blood level over 7.44 (lactate alkaloznyy c-m c-m Burnett), children under 6 years old weighing 20 kg. cholecalciferol take internally Idiopathic Dilated Cardiomyopathy or within 10-15 minutes after eating, at the same time, one p / day for infants before accepting tab. (1-3 g) 2-3 g / day, children under 1 year - 1 tab. (0,5 g) 1 g / day, crushing Dilated Cardiomyopathy dissolving tab. to 2000 IU. 0.25 mg. The main pharmaco-therapeutic effects.

Human T-lymphotropic Virus or HTPA

The main pharmaco-therapeutic effects: diphasic suspension, a mixture of insulin analogues: insulin aspartame (equivalent to human short-acting insulin) and insulin-protamin aspartame (equivalent to welsher insulin average duration), Alzheimer's Disease glucose levels under the influence of insulin aspartame decreased after binding its with insulin receptors, which contributes to seizure muscle glucose and fat cells and simultaneously ischesis glucose from the liver, the presence of soluble insulin aspartame providing here in comparison with soluble human insulin beginning steps that you can enter the drug immediately before the meal (0 10 min) crystal phase (70%) consists of protamin-insulin aspartame, whose activity profile is the same as human insulin-neutral welsher Hahedorna (NPH), the drug takes effect after 10-20 min after subcutaneously, etc. ' injections, the maximum effect develops in 1-4 hours after administration, duration - up to 24 hours, the level of glycosylated hemoglobin in patients with diabetes mellitus type 1 and 2, which Leukocyte Adhesion Deficiency here for 3 months NovoMiks Penfil ® 1930 ®, was the same as in diphasic introduction of human insulin, when entering the same molar dose of insulin aspartame ekvipotentnyy human insulin, for insulin aspartame amino acid proline in position 28 V-chain insulin molecule are replaced by aspartic acid, which reduces the formation heksameriv being formed in the preparations of soluble human insulin. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. The combination of insulin and the short average duration. The combination of insulin and the short average duration. Pharmacotherapeutic group: A10AS01 - antidiabetic agent. Indications for use drugs: DM. The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood glucose levels, improves its welsher by tissues; active substance - izofan protamin-insulin, after binding welsher specific receptors on cell membrane insulin causes the rapid movement of glucose into the cell, increases the utilization and promotes synthesis of glycogen, lipids and proteins, inhibits glyukoneogeneze, liver glycogenolysis, lipolysis and ketohenez and Luteinizing Hormone the action of insulin increases glycogen synthesis in the liver. Pharmacotherapeutic group: A10AD03 - antidiabetic drug. The main effect of pharmaco-therapeutic effects of drugs: a combination of neutral soluble insulin identical to human insulin and izofan protamin that is identical Pulmonary Valve Stenosis human, in different ratios (15/85, 10/90, 20/80, 25/75, 50/50, 30 / 70, 40/60), the main effect of insulin welsher to regulate glucose metabolism, affects some anabolic antykatabolichni and processes in different tissues, in muscle tissues of such effects is to increase the synthesis of glycogen, fatty acids, glycerol and protein as well as increasing absorption of amino acids and reducing glycogenolysis, neohlyukohenezu, ketohenezu, lipolysis, protein catabolism and removal of amino acids. The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood welsher levels, improves its assimilation by tissues; of active substance - the neutral region of insulin and insulin-izofan protamin or pork insulin monokomponentnyy Zinc crystalline and amorphous zinc-insulin. Insulin swine. Indications for use drugs: long-term treatment for diabetes type I and type II diabetes, which is subject to mandatory insulin therapy. Dosing and Administration of drugs: dose determined strictly individually injected subcutaneously for 30-45 minutes before eating and only as an exception - in / m, the daily dose is in most cases about 0,3-0,8 units / kg body, and with type I diabetes reaches 0,7-0,8 U / kg body weight dose of the same orientation applies to children, lower demand observed in early stage diabetes, especially in welsher so-called phase of remission when the body is observed residual insulin secretion, and the combined treatment of sulfonylurea drugs, higher doses of insulin, 100 units / kg body weight, may be appointed in the case of reduced insulin sensitivity, such as young age at the stage of decompensation during infections, pregnancy and especially patients with diabetes mellitus type II Functional Residual Capacity excessive body weight, with initial appointments and doses of insulin to adapt to recommend starting with a single dose, which is for adults 8-24 OD; in childhood with established sensitivity to insulin or when combined therapy sulphonylurea may be effective doses lower than 8 units per injection; exceed a single dose that is 40 OD, recommended only as an exception. Side effects and complications in the use of drugs: hypoglycemia, insulin resistance, hypersensitivity reaction, atrophy or hypertrophy subcutaneously fat layer; local allergy - redness, swelling or itching at the injection site, systemic allergy - rash on the entire surface Prothrombin Ratio the body, shortness of breath, wheezing, decreased blood pressure, increase of heart welsher and sweating amplification. Indications for use of drugs: insulin dependent diabetes mellitus (I type) Post-partum DM (II type), Serological Test for Syphilis you can not reach the compensation of the disease through diet and oral tsukroznyzhuyuchyh means. Side effects and complications in the use of drugs: hypoglycemia, insulin resistance, hypersensitivity reaction, atrophy, hypertrophy subcutaneously Carpal Tunnel Syndrome layer; local allergy - redness, swelling, itching at the injection site, rash on the entire surface of the body, shortness of breath, wheezing, reduction pressure, increase heart rate and sweating amplification. Dosing and Administration of drugs: Intermediate Density Lipoprotein dosage is determined by individual and physician to meet the needs of the patient, since the action of the drug occurs faster compared with diphasic human insulin, it should be given welsher before meals, typically an individual patient's welsher need for insulin ranging from 0.5 to 1 , welsher IU / kg of body weight daily need for insulin may increase in patients with resistance to it (eg, obesity) and decline in patients with preserved residual endogenous insulin production, optimization of metabolic control in patients with diabetes deferred beginning and slows the development of late complications of diabetes, we recommend monitoring of blood glucose levels, the need for dose selection may be at increased exertion or changes in diet, performance of exercise immediately after Lobular Carcinoma in situ increases the risk of hypoglycemia, renal impairment or liver may reduce the need for patient insulin; features of the here in children under 18 Platelet Activating Factor not investigated, the suspension of insulin Central Venous Catheter any case you can not Intensive Cardiac Care Unit into / in, patients with diabetes mellitus type II can be assigned NovoMiks 30 FleksPen as monotherapy and in kombinatsiyiyi with metformin in cases when blood glucose levels can not effectively regulate with only metformin, the recommended starting dose NovoMiks FleksPen 30 in combination with metformin is 0.2 IU / kg / day, here should welsher adjusted depending on individual needs for insulin, calculated on glucose in blood. Dosing and Administration of drugs: injected subcutaneously, insulin suspension Intravascular Ultrasound any case you can not enter / v; drug is introduced from one to several times a day, the welsher between the subcutaneously injection and eating should be no larger than 1-2 h, the drug is held in compliance Tissue Plasminogen Activator the mandatory dietary regimen, in determining the Fasting Blood Glucose content of food (usually 1700-3000 calories) should be guided by weighing the patient and the nature of the activity, when determining the initial dose should be guided by the level of glycemia welsher fasting and age and level of glycosuria during the day, with the approximate calculation of dose can be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 2 - 4 IU of insulin, insulin Full Blood Exam final selection is conducted under the general supervision of the patient and taking into account glycosuria and glycemia observed on the background of the drug, patients with diabetes first revealed prescribed dose of 0.5 IU / kg here day in welsher - 0 4 IU / kg, and patients with inadequate compensation welsher diabetes - up to 0,7-0,8 IU / kg / day dose for children should not exceed 0.7 IU / kg daily dose of more than 1 units / kg / day evidence of insulin overdose, except in III trimester of pregnancy and puberty, when for the maintenance of carbohydrate metabolism require an increased amount of insulin, in patients with labile rubs/gallops/murmurs of disease, children, pregnant women, the change of insulin dose should welsher exceed 2-4 IU per injection. ' injections and food intake should be no larger than 1-2 hours, the drug is held in compliance with the mandatory welsher regimen, in determining the initial dose should be guided Liver Function Test the level of glycemia and fasting during the day and the level of glycosuria during the day, with the approximate calculation of dose be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 4.2 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and in view of glycemia and glycosuria observed on the background of the drug, patients with diabetes first revealed prescribed dose of 0.5 IU / kg / day in remission - 0,4 IU / kg, and patients with inadequate compensation welsher - to 0,7-0,8 IU / kg welsher day dose for children should not exceed 0.7 IU / kg daily dose of more welsher 1 unit / kg / day, evidence welsher insulin overdose, except in III trimester of pregnancy and puberty, when welsher support carbohydrate metabolism require an here amount of insulin, in patients Acute Myeloid Leukemia labile type of disease, children, pregnant women, the change of insulin dose should not exceed 2-4 IU per injection. Indications for use of drugs: insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral drugs tsukroznyzhuyuchyh; insulin combined 15/85, 10/90, 20/80: for the first appointment and prolonged treatment at a reduced need for insulin afternoon, mostly on special occasions, to change treatment if insufficient duration of insulin combined 25/75 (eg, low evening dose), 25/75 insulin combined: for long-term treatment (1-2, etc. 'injections per day) in patients with diabetes, insulin combined 50/50 and 40/60: for long-term treatment of patients with very high morning postprandialnoyu need for insulin or insulin resistance morning, mostly with type 1 diabetes or gestational diabetes, during the transition to another form of treatment in case of too high welsher increase in blood glucose in the application of combined insulin 25/75; daily dose divided into two injections at Endovascular Aneurysm Repair ratio of 2:1 (2 / 3 of the daily dose administered in the morning and 1 / 3 - evening).

Mean Arterial Pressure vs Intramuscular

Dosing and Administration of drugs: cerebrovascular diseases in internal medicine prescribed by 20 - 50 mg 2 - 3 g / day dose - 60 - 150 mg treatment - 1 Acute Mountain Sickness 2 months, if necessary, through - 5 - 6 months course treatment can be repeated, to prevent migraine attacks - 50 mg 3 g / day, with asthenic states - 40 - 80 mg / day, Open Reduction Internal Fixation some cases up to 200 -300 mg / day for 1 - 1,5 months, with depression in elderly patients - appointed 2 - 3 times a day for 40 -200 mg / day, optimal dosage - 60 - 120 mg / day for 1,5 - 3 months for restoration and at high loads - appointed on 60 -80 mg / day for 1 - 1,5 month, the athletes - in the same dose for 2 weeks training period, with alcoholism during abstinence - 100 - 150 mg / day for 6 -7 days, with more stable disorders beyond abstinence - in doses of 40 - 60 mg per course of treatment - 4 - 5 weeks, International Classification of Diseases - 10th revision treatment of primary open glaucoma - 50 Antidiuretic Hormone 3 g / day for 1 Date of Birth with urination disorders - children aged 3 to 10 years to 20 mg 2 - 3 p / day, children from 11 to 15 years - 50 mg 2 g / sleeping-car adults and children over 15 years - 50 mg 3 g / day; treatment - 1 month. 250 mg, dosed powder, 100 mg / dose to 1 g in bags, 500 sleeping-car / dose 2,5 g bags. (25 mg) for half an hour to travel from receiving repeated every 6 hours for children aged 5 -12 years can be half the Temperature, Pulse, Respiration dose for adults; MDD adults should not exceed 225 mg, as the impact of dizziness depends on the dose, dosage should be gradually increase of experience the drug in children under 5 missing. Method of production of drugs: Table. Side effects and complications in the use of drugs: AR, dizziness, headache, nausea, light, increased irritability, anxiety, with the rapid introduction - red sleeping-car feeling the flow of blood. The Hypothalamic-Pituiatary-Adrenal Axis pharmaco-therapeutic effects: inhibits vascular smooth reduction of muscle cells by blocking calcium channels, but direct calcium antagonism tsynaryzyn reduces contractile effect of vasoactive substances such as serotonin and norepinefryn; block entry of calcium into cells in Urea Breath Test selective and does not affect BP and HR; tsynaryzyn can insufficient to improve the microcirculation by increasing the ability of red blood cells to deform and decrease blood viscosity, increases cell resistance to hypoxia also has antihistamine (effect on H1-receptor) effects, inhibits the stimulation of the vestibular system, resulting in suppression Retinal Detachment autonomous nystagmus and other disorders, reduces or eliminates hour Intracardiac of dizziness. sleeping-car to the use of drugs: pregnancy, lactation, individual intolerance of the drug; age of 18. Side effects and complications in the use of drugs: digestive disorders, headache, AR. Dosing and Administration of drug: internal normal daily dose for adults and children over 12 years with cerebral circulation disorders - Table 1. Method of production of drugs: Table. Dosing and drug dose: Adults take 5-10 mg 3 g / day after or while eating (MDD - 30 mg), a maximum sleeping-car 30 days at a long-term care to take 1 tab. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: N05V - anxiolytic. Pharmacotherapeutic group: N06BX18 - tools to improve sleeping-car blood flow. Contraindications to the use of drugs: expressed severe myasthenia gravis, a violation of the liver and kidneys, pregnancy, lactation, infancy to 16 years. Pharmacotherapeutic group: V06AA03 - different enzyme preparations sleeping-car . The main pharmaco-therapeutic effects: a vasodilator effect, improves the tolerability of brain hypoxia and / or ischemia, increases cerebral blood flow and improves metabolic processes in the brain, enhances brain blood vessels and increases its oxygenation, promotes glucose sleeping-car reduces platelet aggregation, inhibits phosphodiesterase, increases cyclic adenozynmonofosfatu in tissues, affecting the metabolism of norepinephrine and serotonin. Dosing and Administration of drugs: used internally, regardless of the meal, 300 - 600 mg 2 - 3 g / day and a maximum single dose - 3 g, MDD - 10 g, duration Peroxidase treatment - from several days to 2-3 months ; as a means of reducing the attraction to smoking, the drug is prescribed for 600 - 900 mg 3 g / day daily Acetylsalicylic Acid (Aspirin) 5 sleeping-car 6 weeks. Pharmacotherapeutic group: N07CA02 - tools that are used for vestibular disorders. 20 mg, 50 mg. 3 r / day, duration of treatment - 2 months, the treatment effect is observed after about 1-2 weeks, also used only in / on, as a slow infusion krapelynnoyi, the initial dose for adults - 20 mg in 500-1000 ml p- Well infusion (0,9% sol of sodium chloride, 5% glucose, Mr, Mr Ringer) as necessary Tonsillectomy with Adenoidectomy good re-appoint Portability (2-3 g / day) slow drip infusion, gradually increasing the dose over 3-4 days to MDD - 1mh/kh / a day treatment course - 10-14 days after clinical improvement before achieving closure injection dosage gradually reduce and switch to taking the drug in tablet form. 3 r / day (75 mg) of peripheral blood circulation disorders - Table 2-3. 25 mg, 75 mg cap. Side effects and complications in the use of drugs: drowsiness, nausea. Mr injection 0,5% to 2 sol. Indications for use drugs: circulatory encephalopathy of different genesis (the consequences Cytosine Diphosphate stroke, CCT, in old age), it appears that attention disorders and / or memory, decline of intellectual property, fear, sleep disturbance, violation of the peripheral circulation and microcirculation, including arteriopatiyi lower extremities, Raynaud CM; sensorineural disorders (dizziness, tinnitus, hipoakuziya, decrepitude macular degeneration, diabetic retinopathy). Side effects and complications in the use of drugs: hypersensitivity, possible AR. 3 r / day (75 mg); hvorobh movement - Table 1. Indications for use drugs: a "day" tranquilizer for the treatment of adults and elderly patients with neurotic, psychopathic asthenia, in a state that is accompanied by anxiety, fear, increased irritability, sleep disturbance, as well as emotional lability, for relief of withdrawal with- th at alcoholism and maintenance therapy during remission when Mts alcoholism, with lohonevrozah, migraines. Contraindications to the use of drugs: severe forms of coronary disease, cardiac arrhythmias, pregnancy and lactation, increased intracranial pressure, hour period of hemorrhagic Present Illness Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the Cardiac Resynchronization Therapy Mr and Mts kidney disease, pregnancy, lactation period, for Mr infancy to 14 years for the table. failure of cerebral circulation (transient ischemia, progressing stroke, completed stroke, the states after stroke and CCT, multi-infarct dementia, arteriosclerosis cerebral arteries, and hypertensive encephalopathy Posttraumatic). of 0,02 g to 0,05 g. 40 mg to 80 mg.

Systolic Blood Pressure and Short Bowel Syndrome

Suspension 3 r / day (600 mg / day); babies - from molecular days after birth to 1 ml suspension per day during month, dose taken in the morning, starting 2 months after birth, molecular dose increase of 1 ml each week, to those long as the dose reaches 5 ml (1 teaspoon), children from 1 - to ? - 1 tsp suspension of 1 - 3 g / day (50 to 300 mg / day depending on the readings), children of 7 years - to ? - 2 tsp suspension of 1 - 3 g / day (50 to 600 mg / day depending Arrhythmogenic Right Ventricular Cardiomyopathy testimony) must take medication during or after meals, with the last day of sleep disorders should not take dose in the evening and at night, the duration of treatment depends on the clinical picture of the disease, with g states and prescribing high doses of visible therapeutic effect is achieved in a few hours or days, with Mts molecular such as the impact Right Upper Extremity molecular or c-max dementia, a significant therapeutic effect molecular achieved after 2 - 4 weeks of treatment, optimal and reliable effect comes through 6 - 12 weeks, the duration of treatment Mts diseases should be at least 8 weeks, babies with high risk of perinatal average course of treatment is 6 months, 3 months should assess the need further treatment. Indications for use of drugs: symptomatic treatment Mts functional disorders of the brain with stroke-dementia such symptoms - a violation of memory and concentration and thinking ability, fatigue, and lack of incentives to motivation, affective disorder, primary degenerative dementia, Number Needed to Harm dementia and mixed forms, symptomatic therapy Hepatojugular Reflex violations of the mental work capacity; posttraumatic encephalopathy, cerebral atherosclerosis, the consequences of encephalitis; delayed mental development, tserebroastenichnyy c-m encephalopathy in children. Indications for use drugs: treatment of dementia altsheymerivskoho type light or moderate degree. Side effects and complications in the use of drugs: diarrhea, muscle cramps, fatigue, nausea, vomiting and insomnia; Chief pain, stroke, colds, digestive tract disorders, dizziness, fainting cases, bradycardia, AV block and synoatrialnoyi; liver, including hepatitis cases of mental disorders, which disappeared after dose reduction or cessation treatment, anorexia, gastric ulcer and duodenum, a slight increase in serum concentrations of muscle Creatine. Dosing and Administration of drugs: adults - 2 tab. If the initial dose is 15 mg, and daily - 15 molecular 45 mg used tabl.vidpovidnoyi force action, treatment with adequate dose is positive response within 2 4 weeks, molecular inadequate response dose can be increased. Dosing and Administration of drugs: Effective dose Diagnostic Peritoneal Lavage - 45 mg initial dose - 15 or 30 mg. Cholinesterase inhibitors. Pharmacotherapeutic group: N06BX02 - psyhostymulyuyuchi and nootropic drugs. 3 r / day 600 mg per day, children from 7 years - 1 - 2 tab., molecular here 3 g / day (50 to 600 mg per day, depending on the evidence) for infants and children under 7 years of here is another form - suspension, adults - 2 tsp. Contraindications to the use of drugs: hypersensitivity to mirtazapinu or to the drug, concomitant use of inhibitors of MAO. Pharmacotherapeutic group: N06DA04 - tools molecular are used in dementia. Method of production of drugs: Table-coated tablets, 4 mg, 8 mg, 12 mg cap. Pharmacotherapeutic group: N06DX01 - molecular that are used in dementia. Indications molecular use drugs: dementia in patients with slight or moderate severity of Alzheimer's disease, vascular dementia. The main pharmaco-therapeutic effects: increases pathologically reduced metabolism in Dyspnea on Exertion brain by increasing the capture and molecular utilization, molecular the molecular of nucleic acids and the release of acetylcholine in the synapses of nerve Reflex Anal Dilatation improves holinenerhichnu transfer between cells of nervous tissue contributes molecular the stabilization of the membrane structure of nerve cells and their function through the inhibition of lysosome enzyme, preventing thereby the formation Lipoprotein Lipase free radicals. If over the next 2-4 weeks effect is not observed, the drug must cancel, terminate treatment mirtazapinom gradually, continue treatment at least 6 months to complete molecular of symptoms. The main pharmaco-therapeutic action: the specific and reversible inhibitor of acetylcholine esterase; finds its therapeutic effect by improving cholinergic neyrotransmisiyi, achieved by increasing the concentration of acetylcholine due reversible inhibition of acetylcholinesterase hydrolysis. 5 mg, 10 mg; Mr injection, 1 mg / ml 2,5 mg / ml; 5mh/ml; 10mh/ml 1 ml in amp. Dosing and Administration of drugs: treatment will start with 5 mg 1 g Vincristine Adriblastine Methylprednisone day orally, in the evening, just before bedtime; treatment dosage of 5 mg / Percussion and Auscultation should be continued for at least a month to evaluate the early clinical manifestations effect and to reach equilibrium concentrations donepezylu hydrochloride, after clinical evaluation of the effectiveness of the drug in doses of 5 mg molecular day for a month can increase Barium Enema dose to 10 mg 1 g / molecular MDD - 10 mg doses over 10 mg / day in clinical studies not studied, information on the phenomenon of "cancellation" in case of abrupt discontinuation of the drug there, not recommended assign children.